drugset
drugset / Trial / NCT06433180

Study of Fecal Microbiota Transplantation (FMT) in Severe IBS Patients

NCT06433180 ↗

Phase 3 Not yet recruiting 150 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this protocol is to evaluate the efficacy of fecal microbiota transplantation (FMT) using oral capsules containing frozen stools vs sham FMT on IBS severity score at 12 weeks in patients with severe irritable bowel syndrome refractory to conventional treatments.

Timeline

Start
2025-07-01
Primary completion
2028-07-15
Completion
2029-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Ornidazole Other / unclassified 24 g Oral

Indications

irritable bowel syndrome